Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Neuroblastoma
56%
Human Pluripotent Stem Cells (hPSCs)
51%
Genetic Aberrations
41%
Germ Cell Tumor
40%
Tumor Subtype
37%
RAS-MAPK Pathway
29%
Copy number Gain
24%
Tumor Protein p53 (TP53)
23%
MEK Inhibition
23%
Human Germ Cells
23%
Therapeutic Vulnerability
22%
Cell-based
21%
Pluripotent
21%
Yolk Sac
20%
Pediatric Cancer
20%
Aberrations
19%
Methylation Biomarker
18%
Liquid Biopsy
18%
Pluripotent Stem Cells
18%
Chromosome 11q
18%
Oncogene
18%
RAS-MAPK
18%
Bcl-2 Family
18%
Low Amplitude
18%
Safety Issues
18%
Tumor Risk
18%
Cell Population
18%
Feeder-free Culture
18%
Murine Double Minute 4 (MDM4)
18%
Loss Amplification
18%
Tumor Progression
18%
Targeted Drugs
18%
Checkpoint Kinase 1 (CHK1)
18%
MYCN Amplification
18%
Relapsed/refractory
18%
Refractory Germ Cell Tumor
18%
Tumor-derived
18%
Predictors of Poor Outcome
18%
Circulating Tumor DNA (ctDNA)
18%
Translation Research
18%
Chromosome 1q
18%
Testicular Germ Cell Tumor
18%
Copy number Alterations
18%
High-dose Chemotherapy
18%
Clinical Outcomes
18%
Trametinib
14%
Pediatric Tumors
14%
Epigenetics
14%
Tumor
13%
Tumor Fraction
12%
Medicine and Dentistry
Germinoma
86%
Ganglioneuroblastoma
56%
Mitogen-Activated Protein Kinase
37%
Tumor
36%
Biological Marker
31%
Cancer
31%
Neoplasm
27%
Cisplatin
24%
Pediatric Cancer
20%
Methylation
18%
Liquid Biopsy
18%
Mediastinal Germ Cell Tumor
18%
Checkpoint Kinase 1
18%
Chromosome 11q
18%
Recurrent Disease
18%
Lethality
18%
Somatics
18%
Circulating Tumor DNA
18%
High Dose Chemotherapy
18%
Diseases
18%
Chromosome
18%
In Vitro
17%
Genetics
15%
Overall Survival
14%
Trametinib
12%
Primary Tumor
10%
Chemotherapy
10%
Dentigerous Cyst
10%
Histology
10%
Heat Map
9%
Pediatrics
9%
Germ Cell
9%
Solid Malignant Neoplasm
8%
Chromosome 3p
8%
Neuroblastoma Cell Line
7%
Leiomyosarcoma
7%
Risk Stratification
6%
Whole Genome Sequencing
6%
Biopsy Technique
6%
Progression Free Survival
6%
Treatment Option
6%
Minimal Residual Disease
6%
microRNA
6%
Genetic Screening
6%
Translational Research
6%
Testis Cancer
6%
Antiapoptotic
6%
Rectum Polyp
6%
Endodermal Sinus Tumor
6%
Biochemistry, Genetics and Molecular Biology
Germ Cell
100%
Stem Cell
67%
Mitogen-Activated Protein Kinase
56%
Chromosome
42%
Genetics
33%
Carcinogenesis
28%
Teratoma
25%
Chromosome 11q
23%
Stem Cell Transplantation
21%
CRISPR/Cas9
21%
Chromosomal Aberration
21%
Genomics
20%
Methylation
18%
Liquid Biopsy
18%
Cisplatin
18%
Oncogene
18%
Chromosome 1q
18%
MDM4
18%
Kinase
18%
Phosphotransferase
18%
Tumor Progression
18%
Germline
18%
Aneuploidy
18%
Embryonic Stem Cell
18%
Synthetic Lethality
18%
Trametinib
12%
Chromosome 6
11%
Trisomy
11%
DNA Repair
10%
Vitronectin
9%
Autosome
8%
Overall Survival
8%
Synteny
7%
Chromosome 12
7%
Tumor Suppressor Protein
7%
Preclinical Study
6%
High Throughput Screening
6%
Survival Rate
6%
